drugset / Trial / NCT03224260
To Evaluate the Safety and Pharmacokinetics of BMS-986177 in Healthy Japanese Participants
RandomizedSequentialQuadruple-blindOther
Summary
Access the safety, tolerability, and pharmacokinetics of BMS-986177 in healthy Japanese participants after multiple doses are administered.
Timeline
- Start
- 2017-06-28
- Primary completion
- 2017-11-07
- Completion
- 2017-11-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Milvexian | Small molecule | 50 mg | Oral |
| Subject | Milvexian | Small molecule | 200 mg | Oral |
| Subject | Milvexian | Small molecule | 500 mg | Oral |